South America Blood Transfusion Diagnostics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Instruments & Kits and Reagents), Application (Blood Grouping and Disease Screening), and End User (Hospitals, Diagnostic Laboratories, Blood Banks, and Plasma Fractionation Companies)
The SAM blood transfusion diagnostics market is expected to grow from US$ 217.55 million in 2022 to US$ 302.89 million by 2028. It is estimated to grow at a CAGR of 5.7% from 2022 to 2028.
Technological Developments in Blood Transfusion Diagnostics
Blood Transfusion Diagnostics are usually deployed during long-hour surgeries, such as kidney transplants, and in cases of emergencies. These surgeries are associated with the chances of excessive blood loss, which makes it difficult to make up for the blood loss with new blood, especially in the case of rare blood groups. Due to the ample demand, key players in the blood transfusion diagnostics market offer advanced and fully automated blood transfusion diagnostics that reduce human interventions. For instance, in April 2019, BD launched its BD BACTEC quality control media to help identify contaminated platelet units during transfusions. Moreover, many companies employed strategic activities, such as acquisitions, partnerships, and other activities, to capture the market. For instance, in December 2019, Getinge purchased Applikon Biotechnology, a leader in the development and supply of innovative bioreactor systems from the laboratory to the industrial scale. In October 2019, Medtronic acquired AV Medical Technologies. Thus, such advancements are likely to bring new trends in the blood transfusion diagnostics market in the coming years.
Market Overview
Brazil is one of the largest countries in SAM. It has a well-established medical device industry regulated by the Brazilian National Health Surveillance Agency (ANVISA). Similarly, the National Institute of Metrology Standardization and Industrial Quality (INMETRO) sets the standards and guidance for companies in the medical device industry in the country. Brazil has the most significant medical equipment industry in the region and is the largest importer of medical devices for the US as it imports ~30% of medical devices from the US. Moreover, sepsis is a severe health issue in Brazil, and this condition requires blood transfusion as a line of treatment. A study published on SciELO from Brazil in 2022 demonstrated that sepsis prevalence is 30% in Brazilian ICUs, while the hospital mortality rate for ICU patients is 55%. Reasons for the significant burden of sepsis include inadequacy of clean water, sanitation, and nutrition; insufficiency of vaccination; low access to intensive care services; and increased incidence of healthcare-associated infections. Therefore, the growing prevalence of sepsis is one of the factors contributing to the blood transfusion diagnostics market growth in Brazil. Furthermore, according to the Brazilian Ministry of Health, 1.9% of the Brazilian population donates blood yearly, accounting for ~4 million blood donations. In Brazil, ~3 million units of blood are collected each year, with the public system accounting for ~70% of donations in these areas. Thus, the abovementioned factors propel the demand for blood transfusion diagnostics in Brazil.
SAM Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
SAM Blood Transfusion Diagnostics Market Segmentation
The SAM blood transfusion diagnostics market is segmented based on product, application, end user, and country.
- Based on product, the SAM blood transfusion diagnostics market is bifurcated into instruments & kits and reagents. The instruments & kits segment held the larger market share in 2022.
- Based on application, the SAM blood transfusion diagnostics market is bifurcated into blood grouping and disease screening. The disease screening segment held the larger market share in 2022.
- Based on end user, the SAM blood transfusion diagnostics market is segmented into hospitals, diagnostic laboratories, blood banks, and plasma fractionation companies. The blood banks segment dominated the market in 2022.
- Based on country, SAM blood transfusion diagnostics market has been categorized into Brazil, Argentina, and Rest of SAM. Our regional analysis states that Brazil dominated the market in 2022.
Abbott; BAG Diagnostics GmbH; Bio-Rad Laboratories, Inc.; DiaSorin S.p.A.; F. Hoffmann-La Roche Ltd; Grifols, S.A.; Immucor, Inc.; Ortho Clinical Diagnostics (QuidelOrtho Corporation); Quotient Limited; and Thermo Fisher Scientific Inc. are the leading companies operating in the SAM blood transfusion diagnostics market.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 SAM Blood Transfusion Diagnostics Market – By Product
1.3.2 SAM Blood Transfusion Diagnostics Market – By Application
1.3.3 SAM Blood Transfusion Diagnostics Market – By End User
1.3.4 SAM Blood Transfusion Diagnostics Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. SAM Blood Transfusion Diagnostics Market – Market Landscape
4.1 Overview
4.2 SAM PEST Analysis
4.3 Experts Opinion
5. SAM Blood Transfusion Diagnostics Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rapid Increase in Chronic Diseases
5.1.2 Need for Blood Transfusion due to Rise in Organ Transplants Surgeries
5.2 Market Restraints
5.2.1 Problems associated with Blood Transfusion Services
5.3 Market Opportunities
5.3.1 Elevated Healthcare Expenditure in Emerging Economies
5.4 Future Trends
5.4.1 Technological Developments in Blood Transfusion Diagnostics
5.5 Impact Analysis
6. Blood Transfusion Diagnostics Market– SAM Analysis
6.1 SAM Blood Transfusion Diagnostics Market Revenue Forecast and Analysis
7. SAM Blood Transfusion Diagnostics Market Analysis – By Product
7.1 Overview
7.2 SAM Blood Transfusion Diagnostics Market Revenue Share, by Product (2021 and 2028)
7.3 Instruments and Kits
7.3.1 Overview
7.3.2 Instruments and Kits: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
7.4 Reagents
7.4.1 Overview
7.4.2 Reagents: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
8. SAM Blood Transfusion Diagnostics Market Analysis – By Application
8.1 Overview
8.2 SAM Blood Transfusion Diagnostics Market Revenue Share, by Application (2021 and 2028)
8.3 Disease Screening
8.3.1 Overview
8.3.2 Disease Screening: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
8.4 Blood Grouping
8.4.1 Overview
8.4.2 Blood Grouping: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
9. SAM Blood Transfusion Diagnostics Market Analysis – By End User
9.1 Overview
9.2 SAM Blood Transfusion Diagnostics Market Share, by End User, 2021 and 2028, (%)
9.3 Blood Banks
9.3.1 Overview
9.3.2 Blood Banks: Blood Transfusion Diagnostics Market, Revenue and Forecast to 2028 (US$ Million)
9.4 Hospitals
9.4.1 Overview
9.4.2 Hospitals: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
9.5 Diagnostic Laboratories
9.5.1 Overview
9.5.2 Diagnostic Laboratories: Blood Transfusion Diagnostics Market, Revenue and Forecast to 2028 (US$ Million)
9.6 Plasma Fractionation Companies
9.6.1 Overview
9.6.2 Plasma Fractionation Companies: Blood Transfusion Diagnostics Market, Revenue and Forecast to 2028 (US$ Million)
10. SAM Blood Transfusion Diagnostics Market Analysis – Country Analysis
10.1 SAM Blood Transfusion Diagnostics Market
10.1.1 Overview
10.1.3 SAM: Blood Transfusion Diagnostics Market, by Country, 2021 & 2028 (%)
10.1.3.1 Brazil: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.1.3.1.1 Overview
10.1.3.1.1 Brazil Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
10.1.3.1.2 Brazil: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
10.1.3.1.3 Brazil: Blood Transfusion Diagnostics Market Revenue and Forecasts To 2028, By Application (US$ Million)
10.1.3.1.4 Brazil: Blood Transfusion Diagnostics Market Revenue and Forecasts To 2028, By End User (US$ Million)
10.1.3.2 Argentina: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.1.3.2.1 Overview
10.1.3.2.2 Argentina Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
10.1.3.2.3 Argentina: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
10.1.3.2.4 Argentina: Blood Transfusion Diagnostics Market Revenue and Forecasts To 2028, By Application (US$ Million)
10.1.3.2.5 Argentina: Blood Transfusion Diagnostics Market Revenue and Forecasts To 2028, By End User (US$ Million)
10.1.3.3 Rest of the SAM: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.1.3.3.1 Overview
10.1.3.3.2 Rest of the SAM Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
10.1.3.3.3 Rest of SAM: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
10.1.3.3.4 Rest of SAM: Blood Transfusion Diagnostics Market Revenue and Forecasts To 2028, By Application (US$ Million)
10.1.3.3.5 Rest of SAM: Blood Transfusion Diagnostics Market Revenue and Forecasts To 2028, By End User (US$ Million)
11. Industry Landscape
11.1 Overview
11.2 Inorganic Growth Strategies
11.2.1 Overview
11.3 Organic Growth Strategies
11.3.1 Overview
12. Company Profiles
12.1 Grifols, S.A.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 F. Hoffmann-La Roche Ltd
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Immucor, Inc.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Bio-Rad Laboratories, Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Abbott
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Thermo Fisher Scientific Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Ortho Clinical Diagnostics (QuidelOrtho Corporation)
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 DiaSorin S.p.A.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Quotient Limited
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 BAG Diagnostics GmbH
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. SAM Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (US$ Mn)
Table 2. Brazil: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 3. Brazil: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 4. Brazil: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 5. Argentina: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 6. Argentina: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 7. Argentina: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 8. Rest of SAM: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 9. Rest of SAM: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 10. Rest of SAM: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 11. Recent Inorganic Growth Strategies
Table 12. Recent Organic Growth Strategies
Table 13. Glossary of Terms
LIST OF FIGURES
Figure 1. SAM Blood Transfusion Diagnostics Market Segmentation
Figure 2. SAM Blood Transfusion Diagnostics Market – By Country
Figure 3. SAM Blood Transfusion Diagnostics Market Overview
Figure 4. SAM Blood Transfusion Diagnostics Market, By Product
Figure 5. SAM Blood Transfusion Diagnostics Market, By Country
Figure 6. SAM: PEST Analysis
Figure 7. Experts Opinion
Figure 8. Impact Analysis: SAM Blood Transfusion Diagnostics Market
Figure 9. SAM Blood Transfusion Diagnostics Market– Revenue Forecast and Analysis
Figure 10. SAM Blood Transfusion Diagnostics Market Revenue Share, by Product (2021 and 2028)
Figure 11. SAM Instruments and Kits: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 12. SAM Reagents: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 13. SAM Blood Transfusion Diagnostics Market Revenue Share, by Application (2021 and 2028)
Figure 14. SAM Disease Screening: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 15. SAM Blood Grouping: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 16. SAM Blood Transfusion Diagnostics Market Share, by End User, 2021 and 2028 (%)
Figure 17. SAM Blood Banks: Blood Transfusion Diagnostics Market, Revenue and Forecast to 2028 (US$ Million)
Figure 18. SAM Hospitals: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 19. SAM Diagnostic Laboratories: Blood Transfusion Diagnostics Market, Revenue and Forecast to 2028 (US$ Million)
Figure 20. SAM Plasma Fractionation Companies: Blood Transfusion Diagnostics Market, Revenue and Forecast to 2028 (US$ Million)
Figure 21. SAM Blood Transfusion Diagnostics Market Revenue Overview, by Country, 2021 (US$ Million)
Figure 22. SAM: Blood Transfusion Diagnostics Market, by Country, 2021 & 2028 (%)
Figure 23. Brazil: Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
Figure 24. Argentina: Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
Figure 25. Rest of the SAM: Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
- Abbott
- BAG Diagnostics GmbH
- Bio-Rad Laboratories, Inc.
- DiaSorin S.p.A.
- F. Hoffmann-La Roche Ltd
- Grifols, S.A.
- Immucor, Inc.
- Ortho Clinical Diagnostics (QuidelOrtho Corporation)
- Quotient Limited
- Thermo Fisher Scientific Inc.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the SAM blood transfusion diagnostics market.
- Highlights key business priorities to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the SAM blood transfusion diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth SAM market trends and outlook coupled with the factors driving the blood transfusion diagnostics market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution